G. Elvidge et al., Allelic variation of a BalI polymorphism in the DRD3 gene does not influence susceptibility to bipolar disorder: Results of analysis and meta-analysis, AM J MED G, 105(4), 2001, pp. 307-311
Bipolar disorder is a major psychiatric illness that has evidence for a sig
nificant genetic contribution toward its development. In recent years, the
Hall RFLP (restriction fragment length polymorphism) in the dopamine D3 rec
eptor gene has been examined as a possible susceptibility factor for both s
chizophrenia and bipolar disorder. While analysis in schizophrenia has prod
uced examples of increased homozygosity in patients, less encouraging resul
ts have been found for bipolar disorder. Recently, however, a family-based
association study has found a significant excess of allele 1 and allele 1-c
ontaining genotypes in transmitted alleles to bipolar probands over nontran
smitted controls. In a large bipolar case control sample (n = 454), we have
been unable to replicate the family-based association study (chi-square =
0.137, P = 0.71, 1 df) or detect an effect similar to the positive homozygo
sity findings in schizophrenia (chi-square = 0.463, P = 0.50, 1 df). A meta
analysis of previous association studies also revealed no difference in all
ele distributions between bipolar patients and controls for this polymorphi
sm in ethnically homogeneous samples (odds ratio, OR,= 1.04; P = 0.60; 95%
confidence interval, CI, = 0.89-1.20). In view of this evidence, we conclud
e that variation at the Ball RFLP is not an important: factor influencing t
he susceptibility to bipolar disorder. It remains possible, however, that o
ther sequence variations within the DRD3 gene could play a role. (C) 2001 W
iley-Liss, Inc.